How Will The Radiation Toxicity Treatment Market Expand At A CAGR Of 6.3% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Radiation Toxicity Treatment Market?
The market for treating radiation toxicity has seen significant expansion in the last few years. Expected to surge from $3.74 billion in 2024 up to $3.98 billion in 2025, it is growing at a compound annual growth rate (CAGR) of 6.4%. The past period’s growth has been a result of factors including the global spike in cancer prevalence, an increased preference for radiotherapy as a treatment solution, developments in healthcare infrastructure and facilities, a rise in instances of radiation exposure, and enhanced consciousness regarding radiation toxicity.
The market for radiation toxicity treatment is set to witness a significant rise in its size in the approaching years, with predictions showing it will reach $5.07 billion by 2029, escalating at a compound annual growth rate (CAGR) of 6.3%. Factors that will drive this growth in the projected period are an increased adoption of personalized medicine practices, preventive healthcare measures rising to prominence, a soaring demand for outpatient care amenities, an uptick in global awareness drives about radiation safety, and the launch of various government endeavors aimed at enhancing access to cancer healthcare. Foreseen trends within this duration encompass employing artificial intelligence in creating treatment plans, technological advances in image-guided radiation therapy, progress in stereotactic body radiation therapy, developments in nanoparticle drug delivery systems and the utilization of 3D printing to craft customized treatment strategies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20942&type=smp
What Drivers Are Accelerating Expansion Of The Radiation Toxicity Treatment Market?
The radiation toxicity treatment market is anticipated to experience significant growth due to the escalating rates of cancer. Cancer, which is a class of conditions distinguished by the abnormal growth and spread of rogue cells, can infiltrate and affect other body parts. Lifestyle modifications, contamination of the environment, inherited susceptibility, and enhanced disease detection capabilities contributing to early identification are all factors leading to the increased rate of cancer. The treatment of radiation toxicity is critical for the management of radiation therapy side effects during cancer treatment, facilitating patient healing and curtailing long-term harm. For instance, the Macmillan Cancer Support, a UK nonprofit organization, reported in August 2024 that there are presently over 3 million cancer patients in the UK. These numbers are predicted to rise to 3.5 million by 2025, 4 million by 2030, and ultimately 5.3 million by 2040. Hence, the rising occurrence of cancer is propelling the progress of the radiation toxicity treatment market.
What Are The Primary Segmentation Parameters In The Radiation Toxicity Treatment Market?
The radiation toxicity treatmentmarket covered in this report is segmented –
1) By Product: Colony Stimulating Factors; Potassium Iodide; Prussian Blue; Diethylenetriamine Pentaacetic Acid; Others Products
2) By Indication: Acute Radiation Syndrome; Chronic Radiation Syndrome
3) By Radiation Type: Ionizing Radiation; Non-Ionizing Radiation
4) By End-User: Hospitals; Research And Academic Institutes
Subsegments:
1) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF); Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
2) By Potassium Iodide: Oral Potassium Iodide Tablets; Liquid Potassium Iodide Solution
3) By Prussian Blue: Capsules Of Prussian Blue; Prussian Blue Resin
4) By Diethylenetriamine Pentaacetic Acid (DTPA): DTPA Injection (Calcium And Zinc DTPA)
5) By Other Products: Amifostine; Sodium Bicarbonate; Doxycycline; Activated Charcoal
How Are Industry Trends Steering The Expansion Of The Radiation Toxicity Treatment Market?
Leading businesses in the radiation toxicity treatment market are centering their efforts on technological progress such as improved drug delivery systems. This focus aims to increase the accuracy and efficiency of treatments, improve patient adherence, and slash side effects thus contributing to superior healing results and quicker recovery periods. A drug delivery system is a method that propels medication to designated parts of the body, guaranteeing optimal dosage and efficiency while reducing negative effects. For instance, in December 2023, Coherus BioSciences, a biopharmaceutical entity based in the US, reported that the U.S. FDA had sanctioned UDENYCA ONBODY, a new on-body injector for pegfilgrastim-cbqv. This apparatus is intended for usage the day post-chemotherapy to aid in decreasing the risk of infection brought on by febrile neutropenia. The injector dispenses the medication within just five minutes and houses a retractable needle for improved safety and convenience. Through this approval, Coherus plans to offer a more comfortable and user-friendly remedy for handling chemotherapy side effects.
Which Players Are Shaping The Competitive Landscape Of The Radiation Toxicity Treatment Market?
Major companies operating in the radiation toxicity treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Amgen Inc., Varian Medical Systems, Recipharm AB, Elekta AB, Lantheus Medical Imaging Inc., Ion Beam Applications SA, Accuray Incorporated, Coherus BioSciences Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Theragenics Corp., NorthStar Medical Radioisotopes LLC, Fusion Pharmaceuticals Inc., Blue Earth Diagnostics Ltd., Partner Therapeutics Inc., Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Humanetics Corporation, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/radiation-toxicity-treatment-global-market-report
What Are The Emerging Regional Trends Driving The Radiation Toxicity Treatment Market?
North America was the largest region in the radiation toxicity treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation toxicity treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20942&type=smp
Browse Through More Reports Similar to the Global Radiation Toxicity Treatment Market 2025, By The Business Research Company
Medical Radiation Detection Monitoring And Safety Global Market Report 2025
Radiation Hardened Electronics Global Market Report 2025
Image Guided Radiation Therapy Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
